Our data advance the field and provide novel insights into ESR1 regulation and its interaction with a variety of signaling, permitting a better understanding of breast carcinogenesis, in addition to prospective therapeutics, especially for the ER+/PR+ BC subtype. This evidence concerns the gene ESR1 and breast cancer.